Citations (87)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Sang-Moo Kang, Min-Chul Kim & Richard W Compans. (2012) Virus-like particles as universal influenza vaccines. Expert Review of Vaccines 11:8, pages 995-1007.
Read now
Read now
Delaram Doroud & Sima Rafati. (2012) Leishmaniasis: focus on the design of nanoparticulate vaccine delivery systems. Expert Review of Vaccines 11:1, pages 69-86.
Read now
Read now
Sérgio Costa Oliveira, Guillermo Hernán Giambartolomei & Juliana Cassataro. (2011) Confronting the barriers to develop novel vaccines against brucellosis. Expert Review of Vaccines 10:9, pages 1291-1305.
Read now
Read now
Robert M Paris, Jerome H Kim, Merlin L Robb & Nelson L Michael. (2010) Prime–boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1. Expert Review of Vaccines 9:9, pages 1055-1069.
Read now
Read now
Shuang Liang & George Hajishengallis. (2010) Heat-Labile Enterotoxins as Adjuvants or Anti-Inflammatory Agents. Immunological Investigations 39:4-5, pages 449-467.
Read now
Read now
Articles from other publishers (82)
Fei Zhu, Caixia Tan, Chunhui Li, Shiyang Ma, Haicheng Wen, Hang Yang, Mingjun Rao, Peipei Zhang, Wenzhong Peng, Yanhui Cui, Jie Chen & Pinhua Pan. (2023) Design of a multi-epitope vaccine against six Nocardia species based on reverse vaccinology combined with immunoinformatics. Frontiers in Immunology 14.
Crossref
Crossref
G. F. Leontieva, T. A. Kramskaya, K. B. Grabovskaya, T. V. Gupalova, A. V. Dmitriev & A. N. Suvorov. (2023) Recombinant vaccine candidates with integrated adjuvants provide stimulation of an effective immune response against bacterial infections. Russian Journal for Personalized Medicine 2:6, pages 64-77.
Crossref
Crossref
Woojong Lee & M. Suresh. (2022) Vaccine adjuvants to engage the cross-presentation pathway. Frontiers in Immunology 13.
Crossref
Crossref
Jia Tan, Binbin Ding, Bo Teng, Ping'an Ma & Jun Lin. (2022) Understanding Structure–Function Relationships of Nanoadjuvants for Enhanced Cancer Vaccine Efficacy. Advanced Functional Materials 32:16, pages 2111670.
Crossref
Crossref
Maria Pino, Talha Abid, Susan Pereira Ribeiro, Venkata Viswanadh Edara, Katharine Floyd, Justin C. Smith, Muhammad Bilal LatifGabriela Pacheco-SanchezDebashis Dutta, Shelly Wang, Sanjeev GumberShannon Kirejczyk, Joyce Cohen, Rachelle L. StammenSherrie M. Jean, Jennifer S. Wood, Fawn Connor-Stroud, Jeroen Pollet, Wen-Hsiang Chen, Junfei Wei, Bin Zhan, Jungsoon Lee, Zhuyun Liu, Ulrich Strych, Neeta ShenviKirk Easley, Daniela Weiskopf, Alessandro Sette, Justin Pollara, Dieter Mielke, Hongmei Gao, Nathan EiselCelia C. LeBranche, Xiaoying Shen, Guido FerrariGeorgia D. Tomaras, David C. Montefiori, Rafick P. SekalyThomas H. VanderfordMark A. Tomai, Christopher B. Fox, Mehul S. Suthar, Pamela A. KozlowskiPeter J. HotezMirko Paiardini, Maria Elena Bottazzi & Sudhir Pai Kasturi. (2021) A yeast-expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates. Science Immunology 6:61.
Crossref
Crossref
Bali Pulendran, Prabhu S. Arunachalam & Derek T. O’Hagan. (2021) Emerging concepts in the science of vaccine adjuvants. Nature Reviews Drug Discovery 20:6, pages 454-475.
Crossref
Crossref
Shao Rong Long, Ruo Dan Liu, Deepak Vijaya Kumar, Zhong Quan Wang & Chien-Wen Su. (2021) Immune Protection of a Helminth Protein in the DSS-Induced Colitis Model in Mice. Frontiers in Immunology 12.
Crossref
Crossref
Muhammad Ishfaq, Wanying Hu, Mohammad Zeb Khan, Ijaz Ahmad, Wenxin Guo & Jichang Li. (2020) Current status of vaccine research, development, and challenges of vaccines for Mycoplasma gallisepticum. Poultry Science 99:9, pages 4195-4202.
Crossref
Crossref
Qiao Li, Xiuzhe Ning, Yuepeng Wang, Qing Zhu, Yan Guo, Hao Li, Yusen Zhou & Zhihua Kou. (2019) The Integrity of α-β-α Sandwich Conformation Is Essential for a Novel Adjuvant TFPR1 to Maintain Its Adjuvanticity. Biomolecules 9:12, pages 869.
Crossref
Crossref
Frank Blanco-Pérez, Garibald Papp, Alexandra Goretzki, Tobias Möller, Martina Anzaghe & Stefan Schülke. (2019) Adjuvant Allergen Fusion Proteins as Novel Tools for the Treatment of Type I Allergies. Archivum Immunologiae et Therapiae Experimentalis 67:5, pages 273-293.
Crossref
Crossref
Juliana de Souza Apostólico, Victória Alves Santos Lunardelli, Marcio Massao Yamamoto, Edecio Cunha-Neto, Silvia Beatriz Boscardin & Daniela Santoro Rosa. (2019) Poly(I:C) Potentiates T Cell Immunity to a Dendritic Cell Targeted HIV-Multiepitope Vaccine. Frontiers in Immunology 10.
Crossref
Crossref
Darrick Carter, Malcolm S. Duthie & Steven G. Reed. 2020. Vaccination Strategies Against Highly Variable Pathogens. Vaccination Strategies Against Highly Variable Pathogens
103
127
.
Adil M. Allahverdiyev, Rabia Cakir Koc, Melahat Bagirova, Serhat Elcicek, Serap Yesilkir Baydar, Olga Nehir Oztel, Emrah Sefik Abamor, Sezen Canim Ates, Murat Topuzogullari, Sevil Isoglu Dincer & Zeynep Akdeste. (2017) A new approach for development of vaccine against visceral leishmaniasis: Lipophosphoglycan and polyacrylic acid conjugates. Asian Pacific Journal of Tropical Medicine 10:9, pages 877-886.
Crossref
Crossref
Daniele D'Alonzo, Manuela Cipolletti, Giulia Tarantino, Marcello Ziaco, Giuseppina Pieretti, Alfonso Iadonisi, Giovanni Palumbo, Alberto Alfano, Mariateresa Giuliano, Mario De Rosa, Chiara Schiraldi, Marcella Cammarota, Michelangelo Parrilli, Emiliano Bedini & Maria M. Corsaro. (2016)
A Semisynthetic Approach to New Immunoadjuvant Candidates: Site-Selective Chemical Manipulation of
Escherichia coli
Monophosphoryl Lipid A
. Chemistry - A European Journal 22:31, pages 11053-11063.
Crossref
Crossref
Giada Mondanelli, Claudia Volpi, Roberta Bianchi, Massimo Allegrucci, Vincenzo Nicola Talesa, Ursula Grohmann & Maria Laura Belladonna. (2015) Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetes. Cytokine 75:2, pages 380-388.
Crossref
Crossref
Gregg N. Milligan. 2015. Vaccinology. Vaccinology
93
108
.
D. L. F. Portuondo, L. S. Ferreira, A. C. Urbaczek, A. Batista-Duharte & I. Z. Carlos. (2014) Adjuvants and delivery systems for antifungal vaccines: Current state and future developments. Medical Mycology 53:1, pages 69-89.
Crossref
Crossref
Kartik Sehgal, Kavita M. Dhodapkar & Madhav V. Dhodapkar. (2014) Targeting human dendritic cells in situ to improve vaccines. Immunology Letters 162:1, pages 59-67.
Crossref
Crossref
Mallesh Beesu, Subbalakshmi S. Malladi, Lauren M. Fox, Cassandra D. Jones, Anshuman Dixit & Sunil A. David. (2014)
Human Toll-Like Receptor 8-Selective Agonistic Activities in 1-Alkyl-1
H
-benzimidazol-2-amines
. Journal of Medicinal Chemistry 57:17, pages 7325-7341.
Crossref
Crossref
Giuseppina Pieretti, Manuela Cipolletti, Daniele D’Alonzo, Alberto Alfano, Donatella Cimini, Marcella Cammarota, Giovanni Palumbo, Mariateresa Giuliano, Mario De Rosa, Chiara Schiraldi, Michelangelo Parrilli, Emiliano Bedini & Maria Michela Corsaro. (2014) A combined fermentative-chemical approach for the scalable production of pure E. coli monophosphoryl lipid A. Applied Microbiology and Biotechnology 98:18, pages 7781-7791.
Crossref
Crossref
Yasser A. Aldhamen, Sergey S. Seregin, Charles F. Aylsworth, Sarah Godbehere & Andrea Amalfitano. (2014) Manipulation of EAT-2 expression promotes induction of multiple beneficial regulatory and effector functions of the human innate immune system as a novel immunomodulatory strategy. International Immunology 26:5, pages 291-303.
Crossref
Crossref
Alberto Purwada, Krishnendu Roy & Ankur Singh. (2014) Engineering vaccines and niches for immune modulation. Acta Biomaterialia 10:4, pages 1728-1740.
Crossref
Crossref
Natarajan AyithanSteven B. BradfuteScott M. AnthonyKelly S. StuthmanJohn M. DyeSina BavariMike BrayKeiko Ozato. (2014) Ebola Virus-Like Particles Stimulate Type I Interferons and Proinflammatory Cytokine Expression Through the Toll-Like Receptor and Interferon Signaling Pathways. Journal of Interferon & Cytokine Research 34:2, pages 79-89.
Crossref
Crossref
Helder I Nakaya. 2014. Computational Systems Biology. Computational Systems Biology
331
358
.
Parvinder Pal Singh, Debabrata Bhunia, Yogesh Kumar Verma, Tabasum Sidiq, Anamika Khajuria, Amit Guptha, M. Preethi Pallavi, S. Surya Vamshi, Gulam N Qazi & Halmuthur M. Sampath Kumar. (2013) Synthesis of novel lipidated iridoid glycosides as vaccine adjuvants: 6-O-Palmitoyl Agnuside elicit strong Th1 and Th2 response to ovalbumin in mice. International Immunopharmacology 17:3, pages 593-600.
Crossref
Crossref
Mark T. Orr, Malcolm S. Duthie, Hillarie Plessner Windish, Elyse A. Lucas, Jeffrey A. Guderian, Thomas E. Hudson, Narek Shaverdian, Joanne O'Donnell, Anthony L. Desbien, Steven G. Reed & Rhea N. Coler. (2013) MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvant. European Journal of Immunology 43:9, pages 2398-2408.
Crossref
Crossref
S. Cerpa-Cruz, P. Paredes-Casillas, E. Landeros Navarro, A. G. Bernard-Medina, G. Martínez-Bonilla & S. Gutiérrez-Ureña. (2013) Adverse events following immunization with vaccines containing adjuvants. Immunologic Research 56:2-3, pages 299-303.
Crossref
Crossref
Pieranna ChiarellaStefania De SantisVito M. FazioEmanuela Signori. (2013) Hyaluronidase Contributes to Early Inflammatory Events Induced by Electrotransfer in Mouse Skeletal Muscle. Human Gene Therapy 24:4, pages 406-416.
Crossref
Crossref
George Hajishengallis & Terry D. Connell. (2013) Type II heat-labile enterotoxins: Structure, function, and immunomodulatory properties. Veterinary Immunology and Immunopathology 152:1-2, pages 68-77.
Crossref
Crossref
Ankur Singh, Pallab Pradhan & Krishnendu Roy. 2013. Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines. Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines
161
181
.
Christine Rueckert & Carlos A. Guzmán. (2012) Vaccines: From Empirical Development to Rational Design. PLoS Pathogens 8:11, pages e1003001.
Crossref
Crossref
Sara Lustigman. 2012. Immunity to Parasitic Infection. Immunity to Parasitic Infection
459
470
.
Eric K. Chea, Alberto Fernández-Tejada, Payal Damani, Michelle M. Adams, Jeffrey R. Gardner, Philip O. Livingston, Govind Ragupathi & David Y. Gin. (2012) Synthesis and Preclinical Evaluation of QS-21 Variants Leading to Simplified Vaccine Adjuvants and Mechanistic Probes. Journal of the American Chemical Society 134:32, pages 13448-13457.
Crossref
Crossref
Giovanni Forte, Alessia Rega, Silvana Morello, Antonio Luciano, Claudio Arra, Aldo Pinto & Rosalinda Sorrentino. (2012) Polyinosinic-Polycytidylic Acid Limits Tumor Outgrowth in a Mouse Model of Metastatic Lung Cancer. The Journal of Immunology 188:11, pages 5357-5364.
Crossref
Crossref
Jing Wang, Nancy Tricoche, Lanying Du, Meredith Hunter, Bin Zhan, Gaddam Goud, Elizabeth S. Didier, Jing Liu, Lu Lu, Preston A. Marx, Shibo Jiang & Sara Lustigman. (2012) The Adjuvanticity of an O. volvulus-Derived rOv-ASP-1 Protein in Mice Using Sequential Vaccinations and in Non-Human Primates. PLoS ONE 7:5, pages e37019.
Crossref
Crossref
Jay A. Berzofsky. (2012) Improving Immunotherapy: Revisiting the Immunologist’s Little Secret. Science Translational Medicine 4:120.
Crossref
Crossref
Shayne Cox GadFiona A. Sharp & Ed C. Lavelle. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Jose Rey-Ladino, Allen G. Ross, Allan W. Cripps, Donald P. McManus & Ronald Quinn. (2011) Natural products and the search for novel vaccine adjuvants. Vaccine 29:38, pages 6464-6471.
Crossref
Crossref
Wei Wang & Manmohan Singh. 2011. Development of Vaccines. Development of Vaccines
327
383
.
Madelene Lindqvist, Intawat Nookaew, Ingrid Brinkenberg, Emma Samuelson, Karolina Thörn, Jens Nielsen & Ali M. Harandi. (2011) Unraveling Molecular Signatures of Immunostimulatory Adjuvants in the Female Genital Tract through Systems Biology. PLoS ONE 6:6, pages e20448.
Crossref
Crossref
Jonas J. Forsman & Reko Leino. (2011)
l
-Pentoses in Biological and Medicinal Applications
. Chemical Reviews 111:5, pages 3334-3357.
Crossref
Crossref
Theo P. M. Schetters. 2011. Apicomplexan Parasites. Apicomplexan Parasites
53
73
.
Ivett Jelinek, Joshua N. Leonard, Graeme E. Price, Kevin N. Brown, Anna Meyer-Manlapat, Paul K. Goldsmith, Yan Wang, David Venzon, Suzanne L. Epstein & David M. Segal. (2011) TLR3-Specific Double-Stranded RNA Oligonucleotide Adjuvants Induce Dendritic Cell Cross-Presentation, CTL Responses, and Antiviral Protection. The Journal of Immunology 186:4, pages 2422-2429.
Crossref
Crossref
Wei Wang & Manmohan Singh. (2011) Selection of Adjuvants for Enhanced Vaccine Potency. World Journal of Vaccines 01:02, pages 33-78.
Crossref
Crossref
Luigi Buonaguro, Ena Wang, Maria Tornesello, Franco M Buonaguro & Francesco M Marincola. (2011) Systems biology applied to vaccine and immunotherapy development. BMC Systems Biology 5:1, pages 146.
Crossref
Crossref
Malcolm S. Duthie, Hillarie Plessner Windish, Christopher B. Fox & Steven G. Reed. (2011) Use of defined TLR ligands as adjuvants within human vaccines. Immunological Reviews 239:1, pages 178-196.
Crossref
Crossref
Luigi Buonaguro & Bali Pulendran. (2011) Immunogenomics and systems biology of vaccines. Immunological Reviews 239:1, pages 197-208.
Crossref
Crossref
F. M. Buonaguro, M. L. Tornesello & L. Buonaguro. 2011. Immunologic Signatures of Rejection. Immunologic Signatures of Rejection
141
167
.
Peng Meng Kou & Julia E. Babensee. (2011) Macrophage and dendritic cell phenotypic diversity in the context of biomaterials. Journal of Biomedical Materials Research Part A 96A:1, pages 239-260.
Crossref
Crossref
Julia F. Ridpath, Paul Dominowski, Ramasany Mannan, Robert YanceyJr.Jr., James A. Jackson, Lucas Taylor, Sangita Mediratta, Robert Eversole, Charles D. Mackenzie & John D. Neill. (2010) Evaluation of three experimental bovine viral diarrhea virus killed vaccines adjuvanted with combinations of Quil A cholesterol and dimethyldioctadecylammonium (DDA) bromide. Veterinary Research Communications 34:8, pages 691-702.
Crossref
Crossref
Troy D. Querec & Bali Pulendran. 2010. The Immune Response to Infection. The Immune Response to Infection
547
557
.
Alexander A. Denisov, Yulia S. Korobovtseva, Olga M. Karpova, Alla V. Tretyakova, Larisa V. Mikhina, Arkadyi V. Ivanov, Konstantin M. Salmakov & Roman V. Borovick. (2010) Immunopotentiation of live brucellosis vaccine by adjuvants. Vaccine 28, pages F17-F22.
Crossref
Crossref
Emanuela Signori, Sandra Iurescia, Emanuela Massi, Daniela Fioretti, Pieranna Chiarella, Mariangela De Robertis, Monica Rinaldi, Giancarlo Tonon & Vito Michele Fazio. (2010) DNA vaccination strategies for anti-tumour effective gene therapy protocols. Cancer Immunology, Immunotherapy 59:10, pages 1583-1591.
Crossref
Crossref
Carolyn Driver. (2010) Criteria for choosing hepatitis A vaccine. Practice Nursing 21:9, pages 479-482.
Crossref
Crossref
. (2010) Scientific Opinion on the assessment of allergenicity of GM plants and microorganisms and derived food and feed. EFSA Journal 8:7, pages 1700.
Crossref
Crossref
Peng Meng Kou & Julia E. Babensee. (2010) Validation of a high-throughput methodology to assess the effects of biomaterials on dendritic cell phenotype. Acta Biomaterialia 6:7, pages 2621-2630.
Crossref
Crossref
Nicholas O. Fischer, Ernesto Infante, Tomohiro Ishikawa, Craig D. Blanchette, Nigel Bourne, Paul D. Hoeprich & Peter W. Mason. (2010) Conjugation to Nickel-Chelating Nanolipoprotein Particles Increases the Potency and Efficacy of Subunit Vaccines to Prevent West Nile Encephalitis. Bioconjugate Chemistry 21:6, pages 1018-1022.
Crossref
Crossref
Daniel R. Tonkin, Patricia Jorquera, Tracie Todd, Clayton W. Beard, Robert E. Johnston & Mario Barro. (2010) Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunization. Vaccine 28:18, pages 3238-3246.
Crossref
Crossref
Michelle M. Adams, Payal Damani, Nicholas R. Perl, Annie Won, Feng Hong, Philip O. Livingston, Govind Ragupathi & David Y. Gin. (2010)
Design and Synthesis of Potent
Quillaja
Saponin Vaccine Adjuvants
. Journal of the American Chemical Society 132:6, pages 1939-1945.
Crossref
Crossref
Aditya Pattani, R. Karl Malcolm & Rhonda M. Curran. (2010) Retro-engineering of liposomal vaccine adjuvants: Role of a microarray-based screen. Vaccine 28:6, pages 1438-1439.
Crossref
Crossref
Robert Bergquist & Sara Lustigman. 2010. Important Helminth Infections in Southeast Asia: Diversity and Potential for Control and Elimination, Part B. Important Helminth Infections in Southeast Asia: Diversity and Potential for Control and Elimination, Part B
297
326
.
Kaustabh K. Maiti, Michael DeCastro, Abu-Baker M. Abdel-Aal El-Sayed, Matthew I. Foote, Margreet A. Wolfert & Geert-Jan Boons. (2010) Chemical Synthesis and Proinflammatory Responses of Monophosphoryl Lipid A Adjuvant Candidates. European Journal of Organic Chemistry 2010:1, pages 80-91.
Crossref
Crossref
Madelene Lindqvist, Nazanin Navabi, Marianne Jansson, Emma Samuelson, Åsa Sjöling, Charlotte Örndal & Ali M. Harandi. (2009) Local cytokine and inflammatory responses to candidate vaginal adjuvants in mice. Vaccine 28:1, pages 270-278.
Crossref
Crossref
Karin Loré & Gunilla B Karlsson Hedestam. (2009) Novel adjuvants for B cell immune responses. Current Opinion in HIV and AIDS 4:5, pages 441-446.
Crossref
Crossref
M. Paula Longhi, Christine Trumpfheller, Juliana Idoyaga, Marina Caskey, Ines Matos, Courtney Kluger, Andres M. Salazar, Marco Colonna & Ralph M. Steinman. (2009) Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. Journal of Experimental Medicine 206:7, pages 1589-1602.
Crossref
Crossref
Shuang Liang, Kavita B. Hosur, Hesham F. Nawar, Michael W. Russell, Terry D. Connell & George Hajishengallis. (2009) In vivo and in vitro adjuvant activities of the B subunit of Type IIb heat-labile enterotoxin (LT-IIb-B5) from Escherichia coli. Vaccine 27:32, pages 4302-4308.
Crossref
Crossref
David I. Bernstein, Rhonda D. Cardin, Fernando J. Bravo, Jane E. Strasser, Nicholas Farley, Claudia Chalk, Marla Lay & Jeff Fairman. (2009) Potent Adjuvant Activity of Cationic Liposome-DNA Complexes for Genital Herpes Vaccines. Clinical and Vaccine Immunology 16:5, pages 699-705.
Crossref
Crossref
J. Kovacs-Nolan, L. Latimer, A. Landi, H. Jenssen, R.E.W. Hancock, L.A. Babiuk & S. van Drunen Littel-van den Hurk. (2009) The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody- and cell-mediated immune responses in mice. Vaccine 27:14, pages 2055-2064.
Crossref
Crossref
J. Kovacs-Nolan, J.W. Mapletoft, L. Latimer, L.A. Babiuk & S. van Drunen Littel-van den Hurk. (2009) CpG oligonucleotide, host defense peptide and polyphosphazene act synergistically, inducing long-lasting, balanced immune responses in cattle. Vaccine 27:14, pages 2048-2054.
Crossref
Crossref
Claire J.P. Boog. (2009) Principles of vaccination and possible development strategies for rational design. Immunology Letters 122:2, pages 104-107.
Crossref
Crossref
Fiona A. Sharp, Darren Ruane, Benjamin Claass, Emma CreaghJames Harris, Padma MalyalaManomohan SinghDerek T. O'Hagan, Virginie Pétrilli, Jurg Tschopp, Luke A. J. O'NeillEd C. Lavelle. (2009) Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proceedings of the National Academy of Sciences 106:3, pages 870-875.
Crossref
Crossref
Sang-Moo Kang & Richard W. Compans. (2009) Host responses from innate to adaptive immunity after vaccination: Molecular and cellular events. Molecules and Cells 27:1, pages 5-14.
Crossref
Crossref
Christopher Sundling, Karin Schön, Andreas Mörner, Mattias N. E. Forsell, Richard T. Wyatt, Rigmor Thorstensson, Gunilla B. Karlsson Hedestam & Nils Y. Lycke. (2008) CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization. Journal of General Virology 89:12, pages 2954-2964.
Crossref
Crossref
Angela Meier, Amelia Fisher, Harlyn K. Sidhu, Judy J. Chang, Tom F. Wen, Hendrik Streeck, Galit Alter, Guido Silvestri & Marcus Altfeld. (2008) Rapid loss of dendritic cell and monocyte responses to TLR ligands following venipuncture. Journal of Immunological Methods 339:2, pages 132-140.
Crossref
Crossref
Istvan Toth, Pavla Simerska & Yoshio Fujita. (2008) Recent Advances in Design and Synthesis of Self-Adjuvanting Lipopeptide Vaccines. International Journal of Peptide Research and Therapeutics 14:4, pages 333-340.
Crossref
Crossref
Vanessa K. Berner, Michael E. Sura & Kenneth W. HunterJr.Jr.. (2008) Conjugation of protein antigen to microparticulate β-glucan from Saccharomyces cerevisiae: a new adjuvant for intradermal and oral immunizations. Applied Microbiology and Biotechnology 80:6, pages 1053-1061.
Crossref
Crossref
Richard W. Titball. (2008) Vaccines against intracellular bacterial pathogens. Drug Discovery Today 13:13-14, pages 596-600.
Crossref
Crossref
Kim S. Jones. (2008) Biomaterials as vaccine adjuvants. Biotechnology Progress 24:4, pages 807-814.
Crossref
Crossref
Bali Pulendran & Santa J Ono. (2008) A shot in the arm for mast cells. Nature Medicine 14:5, pages 489-490.
Crossref
Crossref
Christine TrumpfhellerMarina CaskeyGodwin NchindaMaria Paula LonghiOlga MizeninaYaoxing Huang, Sarah J. Schlesinger, Marco Colonna & Ralph M. Steinman. (2008)
The microbial mimic poly IC induces durable and protective CD4
+
T cell immunity together with a dendritic cell targeted vaccine
. Proceedings of the National Academy of Sciences 105:7, pages 2574-2579.
Crossref
Crossref
Bali Pulendran, Hua Tang & Timothy L. Denning. (2008) Division of labor, plasticity, and crosstalk between dendritic cell subsets. Current Opinion in Immunology 20:1, pages 61-67.
Crossref
Crossref
David J Lynn, Geoffrey L Winsor, Calvin Chan, Nicolas Richard, Matthew R Laird, Aaron Barsky, Jennifer L Gardy, Fiona M Roche, Timothy H W Chan, Naisha Shah, Raymond Lo, Misbah Naseer, Jaimmie Que, Melissa Yau, Michael Acab, Dan Tulpan, Matthew D Whiteside, Avinash Chikatamarla, Bernadette Mah, Tamara Munzner, Karsten Hokamp, Robert E W Hancock & Fiona S L Brinkman. (2008) InnateDB: facilitating systems‐level analyses of the mammalian innate immune response. Molecular Systems Biology 4:1.
Crossref
Crossref